# The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis

Study · id `cardio:ct-nct02105519` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02105519](<https://clinicaltrials.gov/study/NCT02105519>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02105519

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02105519. Non-randomized; no masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02105519, source copy `cardio:ctgov-nct02105519-2014-04-07`, retrieved 2026-10-26)
- Start date: 2013-10 (registry gives no type) (ClinicalTrials.gov record NCT02105519, source copy `cardio:ctgov-nct02105519-2014-04-07`, retrieved 2026-10-26)
- Primary completion: 2014-06 (anticipated) (ClinicalTrials.gov record NCT02105519, source copy `cardio:ctgov-nct02105519-2014-04-07`, retrieved 2026-10-26)
- Completion: 2014-06 (anticipated) (ClinicalTrials.gov record NCT02105519, source copy `cardio:ctgov-nct02105519-2014-04-07`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT02105519, source copy `cardio:ctgov-nct02105519-2014-04-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02105519-2014-04-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis
- Condition: Immunogenicity and Adverse Drug Effect of Vaccines Influenza
- Condition: Chronic Kidney Disease
- Intervention (Biological): Seasonal influenza vaccine (AdimFlu-S)
- Lead sponsor: National Cheng-Kung University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: National Cheng-Kung University Hospital (`cardio:org-national-cheng-kung-university-hospital`)

## Provenance

Content hash: 3ca06bb2eae0d7423b89cc9951efa42c333a3db95ec5c9fd65215e421d4d8e45
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
